MolNFT v1 · #7798 · protein

Structure of beta-lactamase GLU166ASP:ASN170GLN mutant

1GHI: “Structure of beta-lactamase GLU166ASP:ASN170GLN mutant”. X-ray diffraction, 1 ligand (CO3), 1 pocket (best druggability 0.29). MolNFT v1 #7798 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB: 1GHI
Type: protein
Length: 257 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase
EC: 3.5.2.6
UniProt: P00807
Ligands: CO3
Pockets: 1 · best druggability 0.29

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 18% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase (EC 3.5.2.6)	protein	257	41% helix, 18% strand	P00807

Ligands and binding sites

CO3 · Carbonate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	59	0.29	0.75	18	CO3

Compared structures

1GHI · Structure of beta-lactamase GLU166ASP:ASN170GLN mutant · the same entry in another collection · chain A against A, TM-score 1.00
P00807 · AlphaFold monomer V2.0 prediction for beta-lactamase (P00807) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P00807
Elsewhere: RCSB PDB 1GHI · PDBe 1GHI · UniProt P00807

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.